Site updated at Wednesday, 22 June 2016

Living with Dementia

Transdermal Rivastigmine

Drug Patch Gets OK for Severe Alzheimer’s

The FDA has expanded the indication for transdermal rivastigmine to include patients with severe Alzheimer’s disease.

The approval means that the transdermal agent is indicated for use in any Alzheimer’s patient, irrespective of disease stage or severity. The expanded indication is the first of its type for any Alzheimer’s drug, according to a statement… Drug Patch Gets OK for Severe Alzheimer’s   

I have Alzheimer Disease

sinus issues1 - cognitive function9 - simplicity1 - korsakoff's syndrome10 - wks4 - rates of dementia1 - preventing alzheimer's1 - latin dementia1 - motor development1 - cognitive symptoms1 - memory loss20 - inheritable dominant disease1 - neurotransmitter1 - synthetic tau fibrils1 - huntington's chorea1 - dsm iv3 - alzheimers society2 - menopause1 - transdermal rivastigmine1 - memory impairments1 - ssri2 - restlessness1 - quality sleep1 - senile atrophy and aphasia1 - fischer1 - parkinsons related dementia1 - insulin-like growth factor-11 - parkinson's sufferer1 - cognitive tests1 - neuritic plaque1 -